Newsroom
October 28, 2024
Naloxone Texas, a program of Be Well Texas at UT Health San Antonio that distributes naloxone to reverse opioid overdoses, was mentioned in this article. Read More (subscription required)
October 28, 2024
Naloxone Texas, a program of Be Well Texas at UT Health San Antonio that distributes naloxone to reverse opioid overdoses, was mentioned in this article. Read More
October 25, 2024
Be Well Clinic, a state-supported initiative within the Be Well Institute on Substance Use and Related Disorders at UT Health San Antonio offers in-person and telehealth substance use treatment and recovery services for anyone in the state, regardless of ability to pay.
October 14, 2024
Jennifer Sharpe Potter, PhD, MPH, vice president for research, professor of psychiatry and behavioral sciences and founding director of the Be Well Institute on Substance Use and Related Disorders, was quoted in this article. Read More (subscription required)
September 30, 2024
Charles P. France, PhD, to lead methocinnamox drug development program The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded a $12 million cooperative agreement (U01) from the National Institutes of Health’s National Institute on Drug Abuse to further develop methocinnamox (MCAM) as a treatment for opioid use disorder. […]
August 29, 2024
Curtis Bone, MD, MHS, departments of Psychiatry and Behavioral Sciences and Family and Community Medicine, and board-certified addiction medicine physician at the Be Well Institute on Substance Use and Related Disorders, was interviewed for this article. Watch Now